DIKUL - logo
E-viri
Recenzirano Odprti dostop
  • Lead compounds for the deve...
    Iketani, Sho; Forouhar, Farhad; Liu, Hengrui; Hong, Seo Jung; Lin, Fang-Yu; Nair, Manoj S; Zask, Arie; Huang, Yaoxing; Xing, Li; Stockwell, Brent R; Chavez, Alejandro; Ho, David D

    Nature communications, 04/2021, Letnik: 12, Številka: 1
    Journal Article

    We report the identification of three structurally diverse compounds - compound 4, GC376, and MAC-5576 - as inhibitors of the SARS-CoV-2 3CL protease. Structures of each of these compounds in complex with the protease revealed strategies for further development, as well as general principles for designing SARS-CoV-2 3CL protease inhibitors. These compounds may therefore serve as leads for the basis of building effective SARS-CoV-2 3CL protease inhibitors.